North China Pharmaceutical Company Ltd. (600812.SS) SHH
4.47
-0.07(-1.54%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 9.49B |
| Enterprise Value | 16.19B |
| P/E Ratio | 47.62 |
| PEG Ratio | -14.98 |
| Price/Sales Ratio | 0.87 |
| Price/Book Ratio | 1.38 |
| Enterprise/Revenue | 2.04 |
| Enterprise/EBITDA | 21.59 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.02 |
| Operating Margin | 0.05 |
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.03 |
Income Statement
| Revenue | 9.24B |
| Revenue/Share | 5.14 |
| Gross Profit | 2.87B |
| EBITDA | 1.66B |
| Net Income | 183.06M |
| Diluted EPS | 0.11 |
Balance Sheet
| Total Cash | 1.38B |
| Total Cash/Share | 0.81 |
| Total Debt | 11.69B |
| Total Debt/Equity | 2.11 |
| Current Ratio | 0.72 |
| Book Value Per Share | 4.05 |
Price History
| 52-Week Change | -27.55 |
| 52-Week High | 7.46 |
| 52-Week Low | 4.41 |
| Moving Average 50 Days | 5.2 |
| Moving Average 200 Days | 5.66 |
Statistics
| Average Volume | 24.93M |
| Shares Outstanding | 1.72B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.03 |
| Trailing Annual Dividend Yield | 0.67 |
| Payout Ratio | 1.75 |
| Last Split Factor | 196:125 |
| Last Split Date | August 15, 2006 |
